Chondrogenesis of human bone marrow mesenchymal stromal cells in highly porous alginate-foams supplemented with chondroitin sulfate

被引:27
|
作者
Huang, Zhao [1 ]
Nooeaid, Patcharakamon [2 ]
Kohl, Benjamin [1 ]
Roether, Judith A. [3 ]
Schubert, Dirk W. [3 ]
Meier, Carola [1 ]
Boccaccini, Aldo R. [2 ]
Godkin, Owen [1 ]
Ertel, Wolfgang [1 ]
Arens, Stephan [1 ]
Schulze-Tanzil, Gundula [1 ,4 ]
机构
[1] Charite, Dept Orthopaed Trauma & Reconstruct Surg, D-13353 Berlin, Germany
[2] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Polymer Mat, Dept Mat Sci & Engn, Erlangen, Germany
[4] Paracelsus Med Univ, Inst Anat, Nurnberg, Germany
来源
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2015年 / 50卷
关键词
Chondrogenesis; Alginate-foam scaffolds; Chondrocytes; Mesenchymal stromal cells; Chondroitin sulfate; ARTICULAR-CARTILAGE LESIONS; IN-VITRO CHONDROGENESIS; PLATELET-RICH PLASMA; ADULT STEM-CELLS; PORE-SIZE; TISSUE; SCAFFOLDS; KNEE; DIFFERENTIATION; CHONDROCYTES;
D O I
10.1016/j.msec.2015.01.082
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
To overcome the limited intrinsic cartilage repair, autologous chondrocyte or bone-marrow-derived mesenchymal stromal cell (BM-MSC) was implanted into cartilage defects. For this purpose suitable biocompatible scaffolds are needed to provide cell retention, chondrogenesis and initial mechanical stability. The present study should indicate whether a recently developed highly porous alginate (Alg) foam scaffold supplemented with chondroitin sulfate (CS) allows the attachment, survival and chondrogenesis of BM-MSCs and articular chondrocytes. The foams were prepared using a freeze-drying method; some of them were supplemented with CS and subsequently characterized for porosity, biodegradation and mechanical profile. BM-MSCs were cultured for 1-2 weeks on the scaffold either under chondrogenic or maintenance conditions. Cell vitality assays, histology, glycosaminoglycan (sGAG) assay, and type II and I collagen immunolabelings were performed to monitor cell growth and extracellular matrix (ECM) synthesis in the scaffolds. Scaffolds had a high porosity similar to 93-95% with a mean pore sizes of 237 +/- 48 mu m (Alg) and 197 +/- 61 mu m (Alg/CS). Incorporation of CS increased mechanical strength of the foams providing gradually CS release over 7 days. Most of the cells survived in the scaffolds. BM-MSCs and articular chondrocytes formed rounded clusters within the scaffold pores. The BM-MSCs, irrespective of whether cultured under non/chondrogenic conditions and chondrocytes produced an ECM containing sGAGs, and types II and I collagen. Total collagen and sGAG contents were higher in differentiated BM-MSC cultures supplemented with CS than in CS-free foams after 14 days. The cell cluster formation induced by the scaffolds might stimulate chondrogenesis via initial intense cell-cell contacts. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:160 / 172
页数:13
相关论文
共 50 条
  • [41] Xeno-free chondrogenesis of bone marrow mesenchymal stromal cells: towards clinical-grade chondrocyte production
    Maria Skog
    Virpi Muhonen
    Johanna Nystedt
    Roberto Narcisi
    Leena-Stiina Kontturi
    Arto Urtti
    Matti Korhonen
    Gerjo J. V. M. van Osch
    Ilkka Kiviranta
    Cytotechnology, 2015, 67 : 905 - 919
  • [42] Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells
    Datta, Indrani
    Mishra, Swati
    Mohanty, Lipsa
    Pulikkot, Sunitha
    Joshi, Preeti G.
    CYTOTHERAPY, 2011, 13 (08) : 918 - 932
  • [43] HUMAN PLATELET LYSATE IS SUITABLE FOR THE PROPAGATION OF HUMAN BONE MARROW DERIVED MESENCHYMAL STROMAL CELLS
    Loh, Y.
    Sturm, M.
    Costa, M. J.
    Brownrigg, L. M.
    Nichols, S.
    Marks, D. C.
    CYTOTHERAPY, 2019, 21 (05) : S78 - S78
  • [44] Targeting eradication of malignant cells derived from human bone marrow mesenchymal stromal cells
    Yang, Yingbin
    Cai, Shaoxi
    Yang, Li
    Yu, Shuhui
    Jiang, Jiahuan
    Yan, Xiaoqing
    Zhang, Haoxing
    Liu, Lan
    Liu, Qun
    Du, Jun
    Cai, Shaohui
    Sung, K. L. Paul
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (20) : 3329 - 3341
  • [45] Further phenotypic and molecular analysis of highly purified bone marrow stromal/mesenchymal stem cells
    Jones, EA
    Ponchel, F
    Kinsey, SE
    Field, SL
    Straszynski, L
    Emery, P
    McGonagle, D
    BLOOD, 2003, 102 (11) : 360A - 360A
  • [46] Characterization of human cardiac mesenchymal stromal cells and their extracellular vesicles comparing with human bone marrow derived mesenchymal stem cells
    Kang, In Sook
    Suh, Joowon
    Lee, Mi-Ni
    Lee, Chaeyoung
    Jin, Jing
    Lee, Changjin
    Yang, Young Il
    Jang, Yangsoo
    Oh, Goo Taeg
    BMB REPORTS, 2020, 53 (02) : 118 - 123
  • [47] PRODUCTION OF HEPARAN-SULFATE PROTEOGLYCANS BY HUMAN BONE-MARROW STROMAL CELLS
    MORRIS, AJ
    TURNBULL, JE
    RILEY, GP
    GORDON, MY
    GALLAGHER, JT
    JOURNAL OF CELL SCIENCE, 1991, 99 : 149 - 156
  • [48] Molecular profile and cellular characterization of human bone marrow mesenchymal stem cells: Donor influence on chondrogenesis
    Cicione, Claudia
    Diaz-Prado, Silvia
    Muinos-Lopez, Emma
    Hermida-Gomez, Tamara
    Blanco, Francisco J.
    DIFFERENTIATION, 2010, 80 (2-3) : 155 - 165
  • [49] Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media
    Turnovcova, Karolina
    Ruzickova, Katerina
    Vanecek, Vaclav
    Sykova, Eva
    Jendelova, Pavla
    CYTOTHERAPY, 2009, 11 (07) : 874 - 885
  • [50] Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells
    Lipat, Ariel Joy
    Cottle, Chasen
    Pirlot, Bonnie M.
    Mitchell, James
    Pando, Brian
    Helmly, Brian
    Kosko, Joanna
    Rajan, Devi
    Hematti, Peiman
    Chinnadurai, Raghavan
    STEM CELLS TRANSLATIONAL MEDICINE, 2022, 11 (09) : 971 - 986